Back to News
Market Impact: 0.12
AbbVie Highlights New HArmonyCa Results In Patients Using GLP-1 Weight-Loss Drugs
Source: Nasdaq
Healthcare & Biotech
Allergan Aesthetics, an AbbVie company, announced it will present eight scientific posters at the Aesthetic & Anti-Aging Medicine World Congress in Dubai. The posters will feature new and long-term clinical evidence across its aesthetics portfolio; the article text provided does not specify findings or financial implications.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.05
Ticker Sentiment
ABBV0.30
More News
- Sovereign wealth funds' China and Hong Kong investments surge 190% after a bruising slump
- Arcus Biosciences prices $250 million stock offering at $17.50
- AstraZeneca says U.S. FDA approves rare kidney disease drug
- UnitedHealth's Earnings Jumped 60%. Is the Comeback Stock a Buy, Sell, or Hold?
- Moderna is about to release the trial results for its cancer vaccine. A lot is riding on this data.
- Why is Intuitive Surgical stock tumbling today?